Skip to main content
Clinical Trials/NL-OMON49221
NL-OMON49221
Not yet recruiting
Not Applicable

Assessment of myocardial function, metabolism, and perFUSION in early and advanced disease stages of Hypertrophic CardioMyopathy: FUSION-HCM - FUSION-HCM

Vrije Universiteit Medisch Centrum0 sites105 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Enlarged heart muscle disease
Sponsor
Vrije Universiteit Medisch Centrum
Enrollment
105
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • MYBPC3 mutation carrier
  • MYH7 mutation carrier
  • Genotype\-negative first degree relative of a MYBPC3 or MYH7 mutation carriers

Exclusion Criteria

  • \>\=65 years old
  • Diabetes mellitus
  • Claustrophobia
  • Pacemaker/ICD
  • Renal insufficiency \<60 GFR
  • Hypertension
  • Aortic valve disease
  • BMI \>30 kg/m2
  • Left bundle branch block
  • Obstructive coronary artery disease

Outcomes

Primary Outcomes

Not specified

Similar Trials